Top Markets
#1 Bitway Bitway +52.95%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +40.72%
#3 Pons Pons +35.43%
#4 Starpower Starpower +34.87%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +27.49%
#6 SkyAI SkyAI +19.55%
#7 aelf aelf +19.41%
#8 OpenEden OpenEden +19.38%
#9 Ocean Protocol Ocean Protocol +18.44%
#10 Mubarak Mubarak +18.33%
Coin of the day
Bitway Bitway
設定
言語
日本
通貨
USD
テーマ
Human Metabolome Technologies, Inc. Human Metabolome Technologies, Inc.

Human Metabolome Technologies, Inc.

6090
株式のランク #29370
Human Metabolome Technologies, Inc. is a biotechnology company based in... Human Metabolome Technologies, Inc. is a biotechnology company based in Tsuruoka, Japan, established in 2003. It focuses on developing and providing metabolomics technologies and solutions for a range of applications, including drug discovery, disease diagnosis, and food production primarily within Japan. The company offers a comprehensive suite of metabolome analysis services, encompassing global profiling, targeted assays, flux analysis, and lipidomics. Additionally, it develops biomarkers, such as Phosphorylethanolamine, which is measured in blood plasma as a marker for major depressive disorder. HMT's solutions address diverse areas like cancer metabolism, infectious diseases, basic and clinical research, food and nutrition, and microbiome studies. The company also fosters collaborations, notably with the Institute for Advanced Biosciences and Keio University, to further advance metabolome analysis technology.
株価
$3.86
時価総額
$21.49M
変化（1日）
-0.17%
変化（1年）
-25.27%
国
JP
取引 Human Metabolome Technologies, Inc. (6090)

カテゴリー

Healthcare
Human Metabolome Technologies, Inc.（6090）の収益
Aug 2026 時点の収益 TTM: 0
Human Metabolome Technologies, Inc. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Human Metabolome Technologies, Inc. の収益履歴（2026 ～ 2026）
各年末の収益
年 収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH